Advertisement

Topics

Latest Bioinformatics NewsRSS

19:33 EDT 28th March 2017 | BioPortfolio

Lysogene Announces Baseline Data from First International Pivotal Observational Study in MPS IIIA

Study will Function as Pivotal Trial Clinical Control and Assist in a Better Understanding of the Disease Regulatory News: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170328006188/en/ Cognitive Bayley DQ (Graphic: Busine

When should you introduce gluten to your baby?

Infants with a first-degree relative (parent or sibling) with celiac disease, and who carry an at-risk (DQ2 or DQ8) gene, have a higher risk of developing the autoimmune disorder triggered by gluten-containing foods. Many parents, especially those with a family history of celiac disease, are understandably nervous about introducing gluten into their child’s diet. They […]

GENEWIZ To Launch Single-Cell RNA-Seq Services At AACR

SOUTH PLAINFIELD, N.J. and WASHINGTON, March 28, 2017 /PRNewswire/ -- (AACR17, Booth #3431) – Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to per...

SGI-DNA Launches Automated Next-Generation Sequencing Library Construction Kits for the BioXp 3200 System to Expand the Capabilities of the Genomic Workstation

LA JOLLA, Calif., March 28, 2017 /PRNewswire/ -- SGI-DNA Inc., a Synthetic Genomics, Inc. (SGI) company, today announced the launch of Next-Generation Sequencing (NGS) Library Construction Kits for the BioXp™ 3200 System, enabling researchers to automate even more processes in the genomics research continuum. With the new kits, scientists can now prepare DNA samples for NGS applicatio...

Macrogen Leads Precision Medicine by Advancing the Realization of the "$100 Genome Age"

- Completed the Installation of NovaSeq 6000, the Latest Genome Analysis Equipment by Illumina- Capacity for Genome Analysis Service Doubled and Capable of Analyzing More Than 70,000 People Per Year- Leads Precision Medicine by Advancing the Realization of “the $100 Genome Age” Macrogen Inc. (CEO Hyun-yong Jeong, www.macrogen.com) ...

In twisting patent fight, CRISPR Therapeutics scores win in Europe

The European Patent Office intends to grant a patent covering use of CRISPR/cas9 in cells to the University of California, which licenses the gene-editing tech to the company. 

Personal Genome Diagnostics' Expanded PlasmaSELECT™ 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology

BALTIMORE, March 28, 2017 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx) today announced the launch of its improved PlasmaSELECTTM 64 targeted panel for pan-cancer tumor profiling and assessment of microsatellite instability status. PlasmaSELECT 64 identifies clinically actionable and functionally important sequence mutations and structural alterations across multiple cancer types us...

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

Pharma would seemingly best biotech in any competition. A few CEO’s explain why it left the honor of “The World’s First Gene Therapy” to biotech. On July 20, 2012, the world’s first gene therapy, Glybera, received marketing authorization from the EMA. The ... This awesome article Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market? appeared first on Labiotech.eu. ...

Gene Quantum (Suzhou) Raises $5.8 Million In A Round For ADC Drugs

  Life Sciences Jobs   ...

Biogen Loses Gene Therapy Pioneer to REGENXBIO

  Life Sciences Jobs   ...

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) reported that the European Patent Office (EPO) has announced its intention to grant a patent broadly covering CRISPR’s in-licensed gene editing technol...

Cardax Pharmaceuticals Inc. Astaxanthin Compound CDX-085 Stimulates Anti-Aging Gene In Mice

  Life Sciences Jobs   ...

ERS Genomics Release: To Grant Broad Claims On Patent Covering CRISPR-Cas9 Gene Editing Technology

  Life Sciences Jobs   ...

Personal Genome Diagnostics' Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel To Include MSI Analyses For Immuno-Oncology

  Life Sciences Jobs   ...

LogixHealth Publishes ED Facility-Focused Intelligence Briefing: 2017 Emergency Department Outpatient Payment System Update

BEDFORD, MA -- (Marketwired) -- 03/28/17 -- LogixHealth, a leading provider of internet and software enabled coding, billing, analytics and management services for hospital and physician practices nationwide, provides services for millions of Emergency Department (ED) visits nationwide, and has published its newest facility-focused intelligence briefing: 2017 Emergency Department Outpatient Payme...

2020 GeneSystems Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 25012017] Prices from USD $250

Summary20/20 GeneSystems Inc 20/20 Gene is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. It offers tests in the areas such as personalized medicine, early detection of lung cancer, and biological detection. 20/20 Gene's blood test technology is used in the early dete...

MELK Is Not A Cancer Target. Surprise!

The Maternal Embryonic Leucine zipper Kinase (MELK) is definitely an interesting enzyme. It’s been implicated in a number of cancer cell lines, and it also has important roles in the normal cell cycle, in embryogenesis, and other functions. It’s one of those proteins that’s found all across mammalian (and non-mammalian) species, with a lot of sequence

Why some people make stupid choices? Genetics may hold the answer

The premise of the Darwin Awards, [which are annually given to those who “improve our gene pool by removing themselves from it”,] is that common sense is heritable. In other words, we pass it on to our kids. But do we? … Genetics influence all these things. In fact the first law of behavior genetics, says Stuart […] The post

MicroRNA Treatment Restores Nerve Insulation, Limb Function in Mice with MS

CINCINNATI, March 27, 2017 /PRNewswire-USNewswire/ -- Scientists partially re-insulated ravaged nerves in mouse models of multiple sclerosis (MS) and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA. In a study published online March 27 in Developmental Cell, researchers at Cincinnati Children's Hospital Medical Center report that treatment wi...

10x Genomics Launches First High-Throughput Solution for Adaptive Immune System Analysis at Single-Cell Resolution

The Chromium™ Single Cell V(D)J Solution enables the scalable identification of paired T-cell transcripts from hundreds to millions of lymphocytes, an essential capability for immunotherapy development and proliferation 10x Genomics, a company focused on enabling the mastery of biology by

Neurodegenerative Disease Associated with New Gene Variant

One of the major hallmarks of many neurodegenerative orders such as Alzheimer's disease, certain forms of dementia, Parkinsonian syndromes, and chronic traumatic encephalopathy that occurs with repeated head injuries is the cellular pathology known as neurofibrillary tangles (NFTs). While previous studies have shown that the accumulation of NFTs is due to the hyperphosphorylation of the microt...

Scientists call for better basic-clinical genomic research collaborations

In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory , National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell . "Interactions between basic and clinical researchers should be more like a 'vi...

Twist Bioscience Raises $33 Million

SAN FRANCISCO, March 27, 2017 /PRNewswire/ -- Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it raised an additional $33 million. To date, Twist Bioscience has raised a total of $166 million. "It is an exciting time to be leading Twist Bioscience as we expand our reach and continue to deliver industry-leadi...

Aedes aegypti Genome Assembled From Scratch

Scientists use a new technique to piece together the mosquito’s full genome.

Applied Stemcell Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10032017] Prices from USD $250

SummaryApplied Stemcell Inc Applied StemCell is a stem cell and gene editing company which focuses on providing products and services that are enabled by its two gene editing platforms, TARGATT and CRISPR/Cas9. Its portfolio of products includes genome editing products and kits, TARGATT products, immortalization kit and PCR Mycoplasma Detection Kit, among others. Applied StemCell offers genome edi...

Quick Search
Advertisement
 

review and buy Bioinformatics market research data and corporate reports here